242 related articles for article (PubMed ID: 20812236)
21. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
Branger CG; Fetherston JD; Perry RD; Curtiss R
Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
[TBL] [Abstract][Full Text] [Related]
22. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
Sun W; Sanapala S; Henderson JC; Sam S; Olinzock J; Trent MS; Curtiss R
Infect Immun; 2014 Oct; 82(10):4390-404. PubMed ID: 25114109
[TBL] [Abstract][Full Text] [Related]
23. Induction of Protective Antiplague Immune Responses by Self-Adjuvanting Bionanoparticles Derived from Engineered Yersinia pestis.
Wang X; Singh AK; Zhang X; Sun W
Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32152195
[TBL] [Abstract][Full Text] [Related]
24. Complete Protection Against
Zhang W; Song X; Zhai L; Guo J; Zheng X; Zhang L; Lv M; Hu L; Zhou D; Xiong X; Yang W
Front Immunol; 2022; 13():793382. PubMed ID: 35154110
[TBL] [Abstract][Full Text] [Related]
25. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R
Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987
[TBL] [Abstract][Full Text] [Related]
27. Protecting against plague: towards a next-generation vaccine.
Williamson ED; Oyston PC
Clin Exp Immunol; 2013 Apr; 172(1):1-8. PubMed ID: 23480179
[TBL] [Abstract][Full Text] [Related]
28. Protection against pneumonic plague following oral immunization with a non-replicating vaccine.
Jones A; Bosio C; Duffy A; Goodyear A; Schriefer M; Dow S
Vaccine; 2010 Aug; 28(36):5924-9. PubMed ID: 20600517
[TBL] [Abstract][Full Text] [Related]
29. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
Anderson GW; Leary SE; Williamson ED; Titball RW; Welkos SL; Worsham PL; Friedlander AM
Infect Immun; 1996 Nov; 64(11):4580-5. PubMed ID: 8890210
[TBL] [Abstract][Full Text] [Related]
30. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.
Noel BL; Lilo S; Capurso D; Hill J; Bliska JB
Clin Vaccine Immunol; 2009 Oct; 16(10):1457-66. PubMed ID: 19710295
[TBL] [Abstract][Full Text] [Related]
31. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
Uppada SB; Bhat AA; Sah A; Donthamshetty RN
Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
[TBL] [Abstract][Full Text] [Related]
32. Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.
Li B; Du C; Zhou L; Bi Y; Wang X; Wen L; Guo Z; Song Z; Yang R
Clin Vaccine Immunol; 2012 Feb; 19(2):228-34. PubMed ID: 22190397
[TBL] [Abstract][Full Text] [Related]
33. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW
Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965
[TBL] [Abstract][Full Text] [Related]
34. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
[TBL] [Abstract][Full Text] [Related]
35. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
[TBL] [Abstract][Full Text] [Related]
36. Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.
Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
Vaccine; 2008 Nov; 26(50):6329-37. PubMed ID: 18832004
[TBL] [Abstract][Full Text] [Related]
37. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
38. Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague.
Eisele NA; Anderson DM
Clin Vaccine Immunol; 2009 Dec; 16(12):1720-7. PubMed ID: 19828767
[TBL] [Abstract][Full Text] [Related]
39. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.
Galen JE; Wang JY; Carrasco JA; Lloyd SA; Mellado-Sanchez G; Diaz-McNair J; Franco O; Buskirk AD; Nataro JP; Pasetti MF
Infect Immun; 2015 Jan; 83(1):161-72. PubMed ID: 25332120
[TBL] [Abstract][Full Text] [Related]
40. Antibodies and cytokines independently protect against pneumonic plague.
Kummer LW; Szaba FM; Parent MA; Adamovicz JJ; Hill J; Johnson LL; Smiley ST
Vaccine; 2008 Dec; 26(52):6901-7. PubMed ID: 18926869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]